Investigation into the immunological effects of miltefosine, a new anticancer agent under development View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1991-09

AUTHORS

P. Hilgard, E. Kampherm, L. Nolan, J. Pohl, T. Reissmann

ABSTRACT

Miltefosine is the prototype of alkylphosphocholines, a new class of anticancer agents related to alkyl-lysophospholipids. These agents were considered to possess potent immunomodulatory properties. Miltefosine was highly active against the human KB tumour xenograft in nude mice, leading to growth inhibition as well as regression of large established tumours, which suggested that its mode of action was not mediated by the T cell system. In vivo natural killer cell activity was measured by chromium release of YAC-1 cells using spleen cells from treated animals as effector cells. Miltefosine had no significant effect on YAC-1 cytolysis. Similarly, the compound did not induce cytotoxic spleen cells against KB target cells. The results were identical when spleen cells from tumour-bearing animals were used. Humoral antibody production in rats following sheep red blood cell immunization was not changed by miltefosine pretreatment. Finally, the in vitro phagocytic activity of mouse bone marrow macrophages was not stimulated but rather inhibited in a dose-dependent manner. In conclusion, there is no experimental evidence that the miltefosine action is mediated by the host immune system and no major immunotoxicity was observed. More... »

PAGES

403-408

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf01612758

DOI

http://dx.doi.org/10.1007/bf01612758

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027286828

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/1890137


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibody Formation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Squamous Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunity, Cellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Macrophages", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phagocytosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphorylcholine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Inbred Strains", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Spleen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hilgard", 
        "givenName": "P.", 
        "id": "sg:person.01023655171.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023655171.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kampherm", 
        "givenName": "E.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nolan", 
        "givenName": "L.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pohl", 
        "givenName": "J.", 
        "id": "sg:person.0750105001.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750105001.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reissmann", 
        "givenName": "T.", 
        "id": "sg:person.01340535776.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340535776.53"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00391352", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001265313", 
          "https://doi.org/10.1007/bf00391352"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00391352", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001265313", 
          "https://doi.org/10.1007/bf00391352"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(85)90416-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003268028"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(85)90416-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003268028"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02535547", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026546527", 
          "https://doi.org/10.1007/bf02535547"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0277-5379(88)90336-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033699947"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0305-7372(85)90036-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033865428"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1515/znb-1964-1207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040413145"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1515/znb-1964-1207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040413145"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02535540", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044328242", 
          "https://doi.org/10.1007/bf02535540"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/72.1.53", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1081838333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082121534", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1991-09", 
    "datePublishedReg": "1991-09-01", 
    "description": "Miltefosine is the prototype of alkylphosphocholines, a new class of anticancer agents related to alkyl-lysophospholipids. These agents were considered to possess potent immunomodulatory properties. Miltefosine was highly active against the human KB tumour xenograft in nude mice, leading to growth inhibition as well as regression of large established tumours, which suggested that its mode of action was not mediated by the T cell system. In vivo natural killer cell activity was measured by chromium release of YAC-1 cells using spleen cells from treated animals as effector cells. Miltefosine had no significant effect on YAC-1 cytolysis. Similarly, the compound did not induce cytotoxic spleen cells against KB target cells. The results were identical when spleen cells from tumour-bearing animals were used. Humoral antibody production in rats following sheep red blood cell immunization was not changed by miltefosine pretreatment. Finally, the in vitro phagocytic activity of mouse bone marrow macrophages was not stimulated but rather inhibited in a dose-dependent manner. In conclusion, there is no experimental evidence that the miltefosine action is mediated by the host immune system and no major immunotoxicity was observed.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf01612758", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "117"
      }
    ], 
    "name": "Investigation into the immunological effects of miltefosine, a new anticancer agent under development", 
    "pagination": "403-408", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "81fc4881d2084cf12f48c0810d685fc76e5d54d0cffba72a237046a749294221"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "1890137"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7902060"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf01612758"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027286828"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf01612758", 
      "https://app.dimensions.ai/details/publication/pub.1027286828"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:36", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000370_0000000370/records_46777_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF01612758"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf01612758'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf01612758'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf01612758'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf01612758'


 

This table displays all metadata directly associated to this object as RDF triples.

203 TRIPLES      21 PREDICATES      56 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf01612758 schema:about N000089679260490a9793192f7d7f00a8
2 N1ac208d4bbf44e579414d194ea68bf76
3 N451e58f28d5b430ca03ec10caf926254
4 N5289fea13abf481db6184dbcc6dc589a
5 N5b0ca84f254c480988ce24665790a741
6 N6095802b3a83403486475a171b2c1e1a
7 N682d16c2068d4aaf8d60de230eb04f91
8 N8a41d50f2c564bf290c1b52cffa5fb01
9 N9b61c907ba0c4581b06de2759e934538
10 Nb88868684fca4a1ba9494dbcd2f7558c
11 Nbd8a02882e0e48d5b8c5b83590ff16fc
12 Ncfd86fdffa4543f1a769205a082f81dd
13 Nd8f1497f7e754e699f689b52cd5a50ae
14 Ndda25f548a2b4355a2232d91a7631513
15 Ne269bd1a06164e12b01eae25e743abbe
16 Ne652b7ce49354334b42febef3c3451c1
17 Nf311dd8bee6c45d2918d7864752cb2ab
18 Nf32d3f49a3db48f98b6b6136d6160751
19 anzsrc-for:11
20 anzsrc-for:1107
21 schema:author N75c0208b80eb41b391bf237dbac03c9d
22 schema:citation sg:pub.10.1007/bf00391352
23 sg:pub.10.1007/bf02535540
24 sg:pub.10.1007/bf02535547
25 https://app.dimensions.ai/details/publication/pub.1082121534
26 https://doi.org/10.1016/0022-1759(85)90416-8
27 https://doi.org/10.1016/0277-5379(88)90336-7
28 https://doi.org/10.1016/0305-7372(85)90036-2
29 https://doi.org/10.1093/jnci/72.1.53
30 https://doi.org/10.1515/znb-1964-1207
31 schema:datePublished 1991-09
32 schema:datePublishedReg 1991-09-01
33 schema:description Miltefosine is the prototype of alkylphosphocholines, a new class of anticancer agents related to alkyl-lysophospholipids. These agents were considered to possess potent immunomodulatory properties. Miltefosine was highly active against the human KB tumour xenograft in nude mice, leading to growth inhibition as well as regression of large established tumours, which suggested that its mode of action was not mediated by the T cell system. In vivo natural killer cell activity was measured by chromium release of YAC-1 cells using spleen cells from treated animals as effector cells. Miltefosine had no significant effect on YAC-1 cytolysis. Similarly, the compound did not induce cytotoxic spleen cells against KB target cells. The results were identical when spleen cells from tumour-bearing animals were used. Humoral antibody production in rats following sheep red blood cell immunization was not changed by miltefosine pretreatment. Finally, the in vitro phagocytic activity of mouse bone marrow macrophages was not stimulated but rather inhibited in a dose-dependent manner. In conclusion, there is no experimental evidence that the miltefosine action is mediated by the host immune system and no major immunotoxicity was observed.
34 schema:genre research_article
35 schema:inLanguage en
36 schema:isAccessibleForFree false
37 schema:isPartOf N91dca83fac264d5b9f73a651342f3a3f
38 Nda6f6fa2bef743baa499c31770690e2e
39 sg:journal.1313647
40 schema:name Investigation into the immunological effects of miltefosine, a new anticancer agent under development
41 schema:pagination 403-408
42 schema:productId N434201b5885045058280cc7cba1b0ba0
43 N4f1604c072904cfbbd16603a44115848
44 N581625a1b40f4a5c93cecff50d699a4e
45 N5f8001663f8e4b75b09bd22585eeb29d
46 Naae6983d2c6f490888c3e49ad9de179d
47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027286828
48 https://doi.org/10.1007/bf01612758
49 schema:sdDatePublished 2019-04-11T13:36
50 schema:sdLicense https://scigraph.springernature.com/explorer/license/
51 schema:sdPublisher N88333cf14dc84ccb9ded5fe89cb52cb9
52 schema:url http://link.springer.com/10.1007/BF01612758
53 sgo:license sg:explorer/license/
54 sgo:sdDataset articles
55 rdf:type schema:ScholarlyArticle
56 N000089679260490a9793192f7d7f00a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Immunity, Cellular
58 rdf:type schema:DefinedTerm
59 N0f47c9f2d25f4a91b473872041133042 rdf:first N4ec1ff6c449d49ac81e612559e153693
60 rdf:rest N6d1642f592f5453d9db70825f32bc2f5
61 N1ac208d4bbf44e579414d194ea68bf76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Rats
63 rdf:type schema:DefinedTerm
64 N29bebae5b5164276aa158b287914ae2e schema:name Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany
65 rdf:type schema:Organization
66 N3b764458a63e4955aecf691e8f514a4b schema:name Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany
67 rdf:type schema:Organization
68 N434201b5885045058280cc7cba1b0ba0 schema:name readcube_id
69 schema:value 81fc4881d2084cf12f48c0810d685fc76e5d54d0cffba72a237046a749294221
70 rdf:type schema:PropertyValue
71 N451e58f28d5b430ca03ec10caf926254 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Neoplasms, Experimental
73 rdf:type schema:DefinedTerm
74 N4ec1ff6c449d49ac81e612559e153693 schema:affiliation N9afef348a7d2470285ca743ff115487f
75 schema:familyName Kampherm
76 schema:givenName E.
77 rdf:type schema:Person
78 N4f1604c072904cfbbd16603a44115848 schema:name doi
79 schema:value 10.1007/bf01612758
80 rdf:type schema:PropertyValue
81 N5289fea13abf481db6184dbcc6dc589a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Macrophages
83 rdf:type schema:DefinedTerm
84 N581625a1b40f4a5c93cecff50d699a4e schema:name nlm_unique_id
85 schema:value 7902060
86 rdf:type schema:PropertyValue
87 N5b0ca84f254c480988ce24665790a741 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Female
89 rdf:type schema:DefinedTerm
90 N5f8001663f8e4b75b09bd22585eeb29d schema:name pubmed_id
91 schema:value 1890137
92 rdf:type schema:PropertyValue
93 N6095802b3a83403486475a171b2c1e1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Carcinoma, Squamous Cell
95 rdf:type schema:DefinedTerm
96 N61d677a928eb4b8da0470374ef2458cb schema:affiliation Nab37801329f44691b070332a759ea853
97 schema:familyName Nolan
98 schema:givenName L.
99 rdf:type schema:Person
100 N682d16c2068d4aaf8d60de230eb04f91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Male
102 rdf:type schema:DefinedTerm
103 N689ce68cab3b49d4ba3ec127d0f4d9e9 rdf:first sg:person.01340535776.53
104 rdf:rest rdf:nil
105 N6d1642f592f5453d9db70825f32bc2f5 rdf:first N61d677a928eb4b8da0470374ef2458cb
106 rdf:rest Na2c58b8dc45245a58c8b3b5918237876
107 N75c0208b80eb41b391bf237dbac03c9d rdf:first sg:person.01023655171.21
108 rdf:rest N0f47c9f2d25f4a91b473872041133042
109 N88333cf14dc84ccb9ded5fe89cb52cb9 schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 N8a41d50f2c564bf290c1b52cffa5fb01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Phosphorylcholine
113 rdf:type schema:DefinedTerm
114 N91dca83fac264d5b9f73a651342f3a3f schema:volumeNumber 117
115 rdf:type schema:PublicationVolume
116 N9afef348a7d2470285ca743ff115487f schema:name Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany
117 rdf:type schema:Organization
118 N9b61c907ba0c4581b06de2759e934538 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Animals
120 rdf:type schema:DefinedTerm
121 Na2c58b8dc45245a58c8b3b5918237876 rdf:first sg:person.0750105001.98
122 rdf:rest N689ce68cab3b49d4ba3ec127d0f4d9e9
123 Naae6983d2c6f490888c3e49ad9de179d schema:name dimensions_id
124 schema:value pub.1027286828
125 rdf:type schema:PropertyValue
126 Nab37801329f44691b070332a759ea853 schema:name Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany
127 rdf:type schema:Organization
128 Nb88868684fca4a1ba9494dbcd2f7558c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Neoplasm Transplantation
130 rdf:type schema:DefinedTerm
131 Nbd8a02882e0e48d5b8c5b83590ff16fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Humans
133 rdf:type schema:DefinedTerm
134 Nc20d7fd1f0ce4d70a2fdb59c7738bd27 schema:name Department of Experimental Cancer Research, ASTA Pharma AG, Artur-Ladebeck-Stra\e 128-152, W-4800, Bielefeld 14, Federal Republic of Germany
135 rdf:type schema:Organization
136 Ncfd86fdffa4543f1a769205a082f81dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Rats, Inbred Strains
138 rdf:type schema:DefinedTerm
139 Nd8f1497f7e754e699f689b52cd5a50ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Antibody Formation
141 rdf:type schema:DefinedTerm
142 Nda6f6fa2bef743baa499c31770690e2e schema:issueNumber 5
143 rdf:type schema:PublicationIssue
144 Ndda25f548a2b4355a2232d91a7631513 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Phagocytosis
146 rdf:type schema:DefinedTerm
147 Ne269bd1a06164e12b01eae25e743abbe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Antineoplastic Agents
149 rdf:type schema:DefinedTerm
150 Ne652b7ce49354334b42febef3c3451c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Mice
152 rdf:type schema:DefinedTerm
153 Nf311dd8bee6c45d2918d7864752cb2ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Spleen
155 rdf:type schema:DefinedTerm
156 Nf32d3f49a3db48f98b6b6136d6160751 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Tumor Cells, Cultured
158 rdf:type schema:DefinedTerm
159 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
160 schema:name Medical and Health Sciences
161 rdf:type schema:DefinedTerm
162 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
163 schema:name Immunology
164 rdf:type schema:DefinedTerm
165 sg:journal.1313647 schema:issn 0171-5216
166 1432-1335
167 schema:name Journal of Cancer Research and Clinical Oncology
168 rdf:type schema:Periodical
169 sg:person.01023655171.21 schema:affiliation N3b764458a63e4955aecf691e8f514a4b
170 schema:familyName Hilgard
171 schema:givenName P.
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023655171.21
173 rdf:type schema:Person
174 sg:person.01340535776.53 schema:affiliation N29bebae5b5164276aa158b287914ae2e
175 schema:familyName Reissmann
176 schema:givenName T.
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340535776.53
178 rdf:type schema:Person
179 sg:person.0750105001.98 schema:affiliation Nc20d7fd1f0ce4d70a2fdb59c7738bd27
180 schema:familyName Pohl
181 schema:givenName J.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750105001.98
183 rdf:type schema:Person
184 sg:pub.10.1007/bf00391352 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001265313
185 https://doi.org/10.1007/bf00391352
186 rdf:type schema:CreativeWork
187 sg:pub.10.1007/bf02535540 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044328242
188 https://doi.org/10.1007/bf02535540
189 rdf:type schema:CreativeWork
190 sg:pub.10.1007/bf02535547 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026546527
191 https://doi.org/10.1007/bf02535547
192 rdf:type schema:CreativeWork
193 https://app.dimensions.ai/details/publication/pub.1082121534 schema:CreativeWork
194 https://doi.org/10.1016/0022-1759(85)90416-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003268028
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/0277-5379(88)90336-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033699947
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/0305-7372(85)90036-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033865428
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1093/jnci/72.1.53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1081838333
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1515/znb-1964-1207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040413145
203 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...